Sign up

Rubric Capital Management LP

$10.9B assets · 87 holdings · Q2 2026 · Filed 14 AUG 2026

About Rubric Capital Management LP’s 13F portfolio

Rubric Capital Management LP is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Rubric Capital Management LP reported $10.9B across 87 US-listed positions (). Its largest position is TALEN ENERGY CORP (TLN) at 13% of the reported book, and its ten biggest holdings make up 46% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.

$10.9B
Assets (13F)
#455
of 8,839 by size
87
Holdings
46%
Top-10 weight
53
Buys
23
Sells
Top holdings · Q2 2026
87 total
#StockPrice% of portfolioSharesValue
1
OTC: TLN
TALEN ENERGY CORP
$355.91
−1.19%
13%
3.6M$1.4B
2
NASDAQ: FTAI
FTAI AVIATION LTD
$168.18
−2.36%
7.4%
3.0M$811.6M
3
NASDAQ: VTRS
VIATRIS INC
$19.88
−1.97%
5.0%
34.2M$542.6M
4
NYSE: TEVA
TEVA PHARMACEUTICAL INDS LTD
$38.54
−8.74%
4.8%
15.6M$527.7M
5
NASDAQ: GLNG
GOLAR LNG LTD
$40.40
−0.25%
4.2%
9.2M$457.5M
6
NYSE: VST
VISTRA CORP
$124.15
−1.14%
2.6%
1.8M$284.7M
7
NYSE: TAC
TRANSALTA CORP
$12.90
+0.86%
2.6%
20.2M$279.8M
8
NYSE: FLR
FLUOR CORP
$45.73
−3.79%
2.4%
5.0M$262.9M
9
NASDAQ: KNSA
KINIKSA PHARMACEUTICALS INTL
$93.54
−1.59%
2.3%
4.0M$255.8M
10
NASDAQ: BGC
BGC GROUP INC
$11.14
−1.33%
2.3%
23.8M$254.4M
11
NASDAQ: ZM
ZOOM COMMUNICATIONS INC
$83.82
−9.56%
2.2%
2.8M$238.7M
12
NYSE: GIL
GILDAN ACTIVEWEAR INC
$33.95
+1.59%
2.1%
4.5M$232.2M
13
NASDAQ: ARQT
ARCUTIS BIOTHERAPEUTICS INC
$27.17
−1.59%
2.0%
8.3M$216.9M
14
NASDAQ: AMZN
AMAZON COM INC
$257.37
−3.87%
2.0%
900K$214.5M
15
NASDAQ: ROIV
ROIVANT SCIENCES LTD
$38.96
+0.59%
1.9%
6.0M$212.3M
16
NASDAQ: ZYME
ZYMEWORKS INC
$26.86
+3.15%
1.7%
7.0M$183.0M
17
NYSE: AMCR
AMCOR PLC
$42.46
−2.84%
1.7%
4.2M$180.4M
18
NASDAQ: CMPR
CIMPRESS PLC
$54.24
−2.62%
1.6%
1.8M$178.0M
19
NASDAQ: AMRX
AMNEAL PHARMACEUTICALS INC
$21.39
−2.24%
1.6%
10.2M$176.0M
20
NASDAQ: NRIX
NURIX THERAPEUTICS INC
$13.60
−3.55%
1.6%
7.2M$175.3M
21
NYSE: MCY
MERCURY GENL CORP NEW
$82.59
−1.39%
1.5%
1.5M$164.3M
22
NYSE: PFSI
PENNYMAC FINL SVCS INC NEW
$58.40
−2.59%
1.4%
1.7M$148.1M
23
NASDAQ: IART
INTEGRA LIFESCIENCES HLDGS C
$13.55
−2.24%
1.3%
7.8M$139.3M
24
NYSE: DK
DELEK US HLDGS INC NEW
$60.25
−0.12%
1.3%
2.7M$136.5M
25
NASDAQ: LBTYA
LIBERTY GLOBAL LTD
$10.13
−1.94%
1.2%
11.8M$133.6M

Showing 1–25 of 87 positions on this page reported in this 13F.

Sector allocation
  • Healthcare33%
  • Industrials14%
  • Consumer Cyclical7.4%
  • Energy6.0%
  • Utilities5.8%
  • Financial Services5.8%
  • Communication Services4.1%
  • Technology3.9%
  • Consumer Defensive3.6%
  • Real Estate1.2%
  • Basic Materials1.2%
Recent activity · vs 2026-03-31
Bought53
  • AddedFTAIFTAI AVIATION LTD+16.5%$811.6M
  • AddedVTRSVIATRIS INC+2.0%$542.6M
  • AddedTEVATEVA PHARMACEUTICAL INDS LTD+2.1%$527.7M
  • AddedVSTVISTRA CORP+19.7%$284.7M
  • AddedTACTRANSALTA CORP+13.8%$279.8M
  • NewFLRFLUOR CORP—$262.9M
  • AddedKNSAKINIKSA PHARMACEUTICALS INTL+6.7%$255.8M
  • AddedBGCBGC GROUP INC+2.1%$254.4M
  • AddedZMZOOM COMMUNICATIONS INC+176%$238.7M
  • AddedGILGILDAN ACTIVEWEAR INC+222%$232.2M
Sold23
  • ReducedAMRXAMNEAL PHARMACEUTICALS INC−7.9%$176.0M
  • ReducedMCYMERCURY GENL CORP NEW−28.5%$164.3M
  • ReducedECVTECOVYST INC−10.1%$102.2M
  • ReducedEPCEDGEWELL PERSONAL CARE CO−11.4%$95.2M
  • ReducedADEAADEIA INC−50.4%$70.0M
  • ReducedPRMBPRIMO BRANDS CORPORATION−4.0%$65.3M
  • ReducedTRVITREVI THERAPEUTICS INC−32.5%$46.7M
  • ReducedPRLBPROTO LABS INC−77.7%$8.9M
  • ReducedEDSAEDESA BIOTECH INC−2.6%$5.4M
  • ReducedCRICARTERS INC−91.5%$3.6M
5%+ Beneficial Ownership Stakes · 1 activist (13D) · 15 passive (13G)

Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.

#StockType% of classSharesFiled
1
HRTX
HERON THERAPEUTICS, INC. /DE/
13D15.9%30.0MFiled 17 OCT 2025
2
LILA
Liberty Latin America Ltd.
13G9.8%3.8MFiled 15 MAY 2026
3
ZYME
Zymeworks Inc.
13G9.5% · 2 classes7.0MFiled 15 MAY 2026
4
IART
Integra Lifesciences Holdings Corporation
13G9.5%7.4MFiled 09 JUL 2025
5
ECVT
Ecovyst Inc.
13G9.1%10.4MFiled 14 NOV 2025
6
NFE
New Fortress Energy Inc.
13G8.9%24.3MFiled 14 MAY 2025
7
MGTX
MeiraGTx Holdings plc
13G8.8% · 2 classes8.4MFiled 16 NOV 2026
8
KNSA
Kiniksa Pharmaceuticals International, plc
13G7.4% · 2 classes3.3MFiled 13 FEB 2026
9
AVO
Mission Produce, Inc.
13G6.8%6.0MFiled 14 AUG 2026
10
ARQT
Arcutis Biotherapeutics, Inc.
13G6.8%8.3MFiled 13 FEB 2026
11
OPK
OPKO Health, Inc.
13G6.0%47.8MFiled 09 JUL 2025
12
ABEO
Abeona Therapeutics Inc.
13G5.8%3.3MFiled 16 NOV 2026
13
MNKD
MannKind Corporation
13G5.8%18.0MFiled 14 AUG 2026
14
FUN
Six Flags Entertainment Corporation
13G5.8%5.9MFiled 16 NOV 2026
15
QDEL
QuidelOrtho Corporation
13G5.6%3.8MFiled 13 FEB 2026
16
ALVO
Alvotech
13G5.5%19.8MFiled 16 NOV 2026

Showing all 16 disclosed stakes. 3 last disclosed over a year ago (the holder may since have dropped below 5%).

Reading Rubric Capital Management LP’s 13F portfolio

Rubric Capital Management LP’s $10.9B 13F book is spread across 87 reported positions and is concentrated toward its biggest ideas, with the top ten holdings at 46%. The largest positions carry real weight, so how those names perform matters a lot to the overall book. Its five largest positions are TLN, FTAI, VTRS, TEVA and GLNG, led by TALEN ENERGY CORP (TLN) at 13% of the portfolio. The heaviest sector exposure is Healthcare (33%), then Industrials (14%).

What Rubric Capital Management LP changed last quarter

Between 2026-03-31 and Q2 2026, Rubric Capital Management LP was a net buyer: it opened 18 new positions and added to 35 more, while trimming 10 and closing 13 outright. Against a 87-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was FTAI AVIATION LTD (FTAI), and its biggest reduction was AMNEAL PHARMACEUTICALS INC (AMRX).

What a 13F does and doesn’t reveal

A 13F captures only Rubric Capital Management LP’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Rubric Capital Management LP is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.

Frequently asked questions

What is an SEC 13F filing?

A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Rubric Capital Management LP's profile on this page is built directly from those filings.

How current is the 13F data on Rubric Capital Management LP's page?

It reflects Rubric Capital Management LP's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Rubric Capital Management LP files its next quarterly report, this page refreshes automatically.

Can I see Rubric Capital Management LP's complete list of holdings?

This page highlights Rubric Capital Management LP's largest positions rather than all 87 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Rubric Capital Management LP's filings.

Does a 13F show everything Rubric Capital Management LP owns?

No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Rubric Capital Management LP's book rather than its full strategy or total assets.

Is 13F data investment advice?

No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Rubric Capital Management LP made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.

Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.